|
CAS番号. | 496775-61-2 |
化学名: | |
别名: | |
英語化学名: | Eltrombopag |
英語别名: | Sb497115;Promacta;Sb-497115;Eltrombopag;Unii-S56D65xj9g;Eltrombopag Acid;Eltrombopag [inn];EltroMbopag (SB-497115-GR);(Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-;(E)-3\'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2\'-hydroxybiphenyl-3-carboxylic acid |
CBNumber: | CB71463423 |
分子式: | C25H22N4O4 |
分子量: | 442.47 |
MOL File: | 496775-61-2.mol |
|
|
|
|
Eltrombopag 物理性質 |
|
|
貯蔵温度 : |
-20°C Freezer, Under Inert Atmosphere |
|
|
Eltrombopag 化学特性,用途語,生産方法 |
化学的特性
Orange to Red Solid |
|
使用
Eltrombopag (SB-497115-GR, Promacta, Revolade) is a small molecule agonist of the c-mpl (TpoR) receptor with an IC50 of 0.69 μM for the inhibition of hERG K+ channel tail current. In preclinical studies, the compound was shown to interact selectively with |
|
使用
An agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia |
|
|
Eltrombopag 上流と下流の製品情報 |
原材料
|
準備製品
|
Eltrombopag 生産企業 Global( 78)Suppliers |
|
|
|
|
496775-61-2
Eltrombopag
3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
(1,1'-Biphenyl)-3-carboxylic acid, 3'-((2Z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)hydrazino)-2'-hydroxy-
Eltrombopag [inn]
Promacta
Sb497115
Sb-497115
Unii-S56D65xj9g
(E)-3\'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2\'-hydroxybiphenyl-3-carboxylic acid
3-(5-{2-[2-(3,4-diMethylphenyl)-5-Methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]hydrazin-1-ylidene}-6-oxocyclohexa-1,3-dien-1-yl)benzoic acid
EltroMbopag (SB-497115-GR)
(Z)-3'-(2-(1-(3,4-DiMethylphenyl)-3-Methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
(Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-
[1,1'-Biphenyl]-3-carboxylic acid, 3'-[2-[(2Z)-1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-
3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid Eltrombopag
Eltrombopag
3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Acid
|